HALOZYME THERAPEUTICS INCHALO
ASignal's systematic analysis rates HALO as Neutral.
Reflects the latest available analysis · analyzed Oct 8, 2026
The case on HALO
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong revenue growth (47.7% YoY)
- High operating and gross margins (59.8% and 76.27%)
- Exceptional return on equity (173.67%)
- Positive free cash flow ($337.31M)
- Forward P/E of 10.33x suggests growth expectations
- MACD below signal line with negative histogram
- Price below 20-day and 50-day moving averages
- High debt-to-equity ratio (15.18x)
- Elevated price-to-book ratio (87.24x)
- No Reddit mentions, indicating low retail interest
See the full verdict on HALO
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes HALO
Most investors never get a second opinion, let alone several. ASignal runs HALO past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.